Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Long-term Investment Intensity
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Long-term Investment Intensity of 0.9% as of September 2019. Long-term investments of CN¥41.47 Million represent 0.9% of total assets of CN¥4.54 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 002262 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Jiangsu Nhwa Pharmaceutical Co Ltd Long-term Investment Intensity (2016–2018)
This chart shows how Jiangsu Nhwa Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 0.9%, reflecting long-term investments of CN¥41.47 Million against total assets of CN¥4.54 Billion CNY. Explore Jiangsu Nhwa Pharmaceutical Co Ltd (002262) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Jiangsu Nhwa Pharmaceutical Co Ltd (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Jiangsu Nhwa Pharmaceutical Co Ltd from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 002262 company net worth.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.1% | CN¥45.06 Million | CN¥4.03 Billion | ▼ -0.1 pp |
| 2017 | 1.2% | CN¥41.04 Million | CN¥3.30 Billion | ▼ -0.2 pp |
| 2016 | 1.4% | CN¥41.80 Million | CN¥2.97 Billion | — |